Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry-Reference-Cited by-同舟云学术

Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry

Published:2019-02 Issue:2 Volume:31 Page:230-240
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Krüger Kathrin,Krauth Christian,Rossol Siegbert,Mauss Stefan,Boeker Klaus H.W.,Müller Tobias,Klinker Hartwig,Pathil Anita,Heyne Renate,Stahmeyer Jona T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference58 articles.

1. Natural history of acute and chronic hepatitis C;Maasoumy;Best Pract Res Clin Gastroenterol,2012

2. Die Seroepidemiologie der Hepatitis A, B und C in Deutschland;Poethko-Müller;Bundesgesundheitsbl,2013

3. Historical epidemiology of hepatitis C virus (HCV) in selected countries;Bruggmann;J Viral Hepat,2014

4. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

5. New hepatitis C therapies: the toolbox, strategies, and challenges;Pawlotsky;Gastroenterology,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment;The Open Microbiology Journal;2022-07-20

2. Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R);Zeitschrift für Gastroenterologie;2022-07-15

3. Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort;Digestive Diseases and Sciences;2022-05-13

4. Hepatitis C – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung;Springer Reference Pflege – Therapie – Gesundheit;2021

5. Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany;International Journal of Environmental Research and Public Health;2020-01-09